Investigating cannabis use in patients with lung cancer and multiple myeloma during treatment
Official title: A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
Funded at Beckman Research Institute/city of Hope · NIH-10932378 · Data updated 2026-11-12
This study is looking at how people with non-small cell lung cancer and multiple myeloma use cannabis while getting treatment, and it wants to understand how they talk about it with their doctors, so we can learn more about the benefits and risks of cannabis for these patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | September 20, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $572,907 |
| NIH project number | 5U01CA286808-02 |
| Project ID | NIH-10932378 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with non-small cell lung cancer or multiple myeloma who are currently undergoing treatment.
✕Less likely to help
Patients with other types of cancer or those not currently receiving treatment may not benefit from this research.
What this research studies
This research examines how patients with non-small cell lung cancer and multiple myeloma use cannabis while undergoing treatment. It aims to gather information on the prevalence and patterns of cannabis use among these patients, as well as how they communicate about cannabis with their healthcare providers. By addressing the knowledge gap regarding the efficacy and potential side effects of cannabis, the study seeks to provide valuable insights for both patients and clinicians. Participants will be monitored over time to assess the benefits and harms associated with cannabis use during their cancer treatment.
Why it matters
Potential benefit: If successful, this research could help clarify the effects of cannabis on cancer treatment, potentially leading to better-informed decisions for patients.
How similar studies have gone: While there is growing interest in the use of cannabis among cancer patients, this specific approach to studying its effects during treatment is relatively novel and has not been extensively tested.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Lee, Richard T — Beckman Research Institute/city of Hope
- Study coordinator: Lee, Richard T
Related research
Other NIH-funded projects on the same topics.
-
Cannabis Use During Cancer Treatment: What Patients with Lung Cancer or Myeloma Should Know
A large study will follow patients with non-small cell lung cancer or multiple myeloma to understand how cannabis is used during treatment and how it may affect side effects and interactions with cancer therapies.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
-
Understanding how minority stress affects cannabis use in sexual minorities
A research project follows young adult sexual minorities to see how daily stress and coping help explain cannabis use and related problems.
-
Integrative study of multiple myeloma genetics and disease biology
A team at Dana-Farber and partners is pursuing a long-term project to understand the genetic and molecular drivers of multiple myeloma and how treatments interact with disease biology.
-
Terminal cannabinoid CB1 receptor changes in schizophrenia and cannabis use
This grant studies how cannabis use and schizophrenia together affect a brain receptor (CB1) and what that could mean for memory and symptoms.
-
Comparative Modeling to Prevent, Detect Early, and Treat Multiple Myeloma
A research team will build and compare computer models to understand how multiple myeloma develops, can be detected earlier, and treated more effectively.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.